GEMoaB Monoclonals GmbH
Industry / private company
Location:
Dresden,
Germany (DE)
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome (2022)
Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, et al.
Journal article
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML (2021)
Wermke M, Kraus S, Ehninger A, Bargou RC, Goebeler ME, Middeke JM, Kreissig C, et al.
Journal article